Showing results (821-830 of 1,410) with videos related to

Sort By:
Pageof 141
NPJ Parkinson'S Disease|August 4, 2025
Elevated plasma levels of alpha-synuclein are dispensable for Parkinson's disease pathologyJin-Young Jeong, Namsuk Kim, Yan Li, et al.
NPJ Parkinson'S Disease|August 6, 2025
Regulation of polyamine interconversion enzymes affects α-Synuclein levels and toxicity in a Drosophila model of Parkinson's DiseaseBedri Ranxhi, Zoya R Bangash, Zachary M Chbihi, et al.
NPJ Parkinson'S Disease|March 24, 2025
Voluntary exercise alleviates neural functional deficits in Parkinson's disease mice by inhibiting microglial ferroptosis via SLC7A11/ALOX12 axisJinghui Xu, Xiaofei He, Lili Li, et al.
NPJ Parkinson'S Disease|March 22, 2025
Identification of Ser71Arg mutation in RAB32 gene in familial Parkinson's disease from Southern ItalyMonica Gagliardi, Radha Procopio, Grazia Annesi, et al.
NPJ Parkinson'S Disease|July 21, 2017
G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson's diseaseRoger A Barker, Lorenz Studer, Elena Cattaneo, et al.
NPJ Parkinson'S Disease|July 21, 2017
Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal studyKyla-Louise Wood, Daniel J Myall, Leslie Livingston, et al.
NPJ Parkinson'S Disease|July 21, 2017
Beyond patient-centered care: person-centered care for Parkinson's diseaseStephen A Buetow, Pablo Martínez-Martín, Mark A Hirsch, et al.
NPJ Parkinson'S Disease|July 21, 2017
Parkinson's disease as a system-level disorderDaniele Caligiore, Rick C Helmich, Mark Hallett, et al.
NPJ Parkinson'S Disease|August 2, 2017
Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonismPaul Matthew D Pasco, Roland Dominic G Jamora, Raymond L Rosales, et al.
NPJ Parkinson'S Disease|August 3, 2017
Cognitive behavioral therapy for insomnia in Parkinson's disease: a case seriesMeghan Humbert, James Findley, Maria Hernandez-Con, et al.
Pageof 141